May 2024 – Page 23

Enlaza Secures $100M for Groundbreaking Irreversible Protein Binding Technology

12 months ago talkbio0Tagged Biotechnology, Drug Development, Enlaza, Investments, irreversible, Medical Research activity, Protein Binding

Enlaza, funding, investment, protein binding, irreversible, biotechnology, medical research, drug development, therapeutics.

Harmony Pharmaceuticals Expands into Rare Genetic Epilepsies with Acquisition of Epygenix Therapeutics

12 months ago talkbio0Tagged Acquisition (action), CDK-like kinase inhibitors, Collaboration, development aspects, Epygenix, genetic epilepsies, Harmony Pharmaceuticals, Infantile Severe Myoclonic Epilepsy, Mutation, research

Harmony Pharmaceuticals, Epygenix Therapeutics, rare genetic epilepsies, acquisition, treatment, research, development, collaboration, genetic mutations, Dravet syndrome, CDK-like kinase inhibitors

Lilly’s Future Brightens with Increased Visibility on Mounjaro and Zepbound Production Capacity

12 months ago talkbio0Tagged Capacity, Drug Industry, drug manufacturing, Eli Lilly, financial outlook, Mounjaro, production, Zepbound

Lilly, Mounjaro, Zepbound, production capacity, financial outlook, pharmaceutical industry, drug manufacturing.